Redefining COPD care with dupilumab
05 May 2025
During the Singapore launch event hosted by Sanofi for dupilumab, experts discussed the evolving role of immunobiologicals in managing chronic obstructive pulmonary disease (COPD). Internationally renowned pulmonologist Professor Klaus Rabe, The LungenClinic Grosshansdorf & Christian Albrecht University of Kiel, Grosshansdorf, Germany, delivered a keynote lecture. This was followed by a clinically focused panel discussion moderated by Associate Professor Augustine Tee from Changi General Hospital, Singapore, with insights from Assistant Professor Tiew Pei Yee (Singapore General Hospital) and Dr Xu Huiying (Tan Tock Seng Hospital).
Resources
Redefining COPD care with dupilumab
Redefining COPD care with dupilumab